Pharmaron Beijing Co., Ltd. (PHBBF)
1.93
0.00 (0.00%)
USD |
OTCM |
Aug 26, 16:00
Pharmaron Beijing EPS Diluted (Quarterly) : 0.0332 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0332 |
| March 31, 2026 | 0.0267 |
| December 31, 2025 | 0.0415 |
| September 30, 2025 | 0.0348 |
| June 30, 2025 | 0.031 |
| March 31, 2025 | 0.0238 |
| December 31, 2024 | 0.0291 |
| September 30, 2024 | 0.0241 |
| June 30, 2024 | 0.0682 |
| March 31, 2024 | 0.018 |
| December 31, 2023 | 0.0332 |
| September 30, 2023 | 0.0276 |
| June 30, 2023 | 0.035 |
| March 31, 2023 | 0.0288 |
| December 31, 2022 | 0.0326 |
| September 30, 2022 | 0.0307 |
| June 30, 2022 | 0.0181 |
| March 31, 2022 | 0.022 |
| December 31, 2021 | 0.0544 |
| September 30, 2021 | 0.0411 |
| June 30, 2021 | 0.0277 |
| March 31, 2021 | 0.0212 |
| December 31, 2020 | 0.0324 |
| Date | Value |
|---|---|
| September 30, 2020 | 0.0251 |
| June 30, 2020 | 0.0299 |
| March 31, 2020 | 0.0082 |
| December 31, 2019 | 0.0203 |
| September 30, 2019 | 0.0161 |
| June 30, 2019 | 0.0088 |
| March 31, 2019 | 0.0045 |
| December 31, 2018 | 0.0093 |
| September 30, 2018 | 0.0089 |
| June 30, 2018 | 0.0072 |
| March 31, 2018 | 0.0036 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Viva Biotech Holdings | -- |
| ICON plc | 0.9381 |
| Proteome Sciences Plc | -- |
| Champions Oncology, Inc. | -0.048 |
| SPO Global, Inc. | 0.00 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 58.95M |
| Revenue (Quarterly) | 590.13M |
| Total Expenses (Quarterly) | 529.18M |
| Enterprise Value | 4.313B |
| Gross Profit Margin (Quarterly) | 31.01% |
| Profit Margin (Quarterly) | 9.99% |
| Earnings Yield | 7.06% |
| Operating Earnings Yield | 8.85% |
| Normalized Earnings Yield | 6.762 |